Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan

International Journal of Clinical Oncology

Volumn 14, Issue 5, 2009, Pages 397-401

  Shibata, Yoshihiro ^a   Ariyama, Hiroshi ^b   Baba, Eishi ^a   Takii, Yasushi ^a   Esaki, Taito ^b   Mitsugi, Kenji ^c   Tsuchiya, Tanji ^d   Kusaba, Hitoshi ^a   Akashi, Koichi ^a   Nakano, Shuji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c HAMANOMACHI HOSPITAL   (Japan)

^d Sawara Hospital   (Japan)

Author keywords

Allergic reaction; Colorectal cancer; Oxaliplatin

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ADRENALIN; ANTIHISTAMINIC AGENT; DEXAMETHASONE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; GLYCYRRHIZIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; STEROID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; JAPAN; MALE; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; OXYGEN THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-ALLERGIC AGENTS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; DRUG HYPERSENSITIVITY; FEMALE; FLUOROURACIL; HUMANS; JAPAN; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RECURRENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70350508569     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-009-0883-6     Document Type: Article

References (23)

1. A. De Gramont A. Figer M. Seynour, et al. 2000 Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947 10944126
2. G. RM S. D M. RF, et al. 2004 N9741: FOLFOX (oxaliplatin (Oxal)/5-FU/leukovorin (LV)) or reduced dose R-Ifl(CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): final efficacy data from an Intergroup Study J Clin Oncol 23 275
3. P. Tvagi A. Grothey 2006 Commentary on a phase III trial of bevacizumab plus XELOX or FOLFOX4 for first-line treatment of metastatic colorectal cancer: the NO16966 trial Clin Colorectal Cancer 6 261 264 10.3816/CCC.2006.n.044
4. T. Andre C. Boni L. Mounedji-Boudiaf, et al. 2004 Multicenter international study of oxaliplatin/5-fluorouracil/leukovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators: oxaliplatin, fluorouracil and leukovorin as adjuvant treatment for colon cancer N Engl J Med 50 2243 2251
5. R.R. Thomas M.G. Quinn B. Schuler, et al. 2003 Hypersensitivity and idiosyncratic reactions to oxaliplatin Cancer 97 2301 2307 10.1002/cncr.11379 12712487 (Pubitemid 36444076)
6. S.W. Siu R.T. Chan G.K. Au 2006 Hypersensitivity reactions to oxaliplatin:experience in a single institute Ann Oncol 17 2590 2261
7. F. Maindrault-Goebel T. Andre C. Tournigand, et al. 2005 Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients Eur J Cancer 41 2262 2267 10.1016/j.ejca.2005.06.021 1:CAS:528:DC%2BD2MXhtVynurfI 16154353 (Pubitemid 41415602)
8. A. Gowda R. Goel J. Berdzik, et al. 2004 Hypersensitivity reactions to oxaliplatin: incidence and management Oncology 18 1671 1675 15648298
9. G. Brandi M.A. Pantaleo C. Galli, et al. 2003 Hypersensitivity reactions related to oxaliplatin (OHP) Br J Cancer 89 477 481 10.1038/sj.bjc.6601155 1:CAS:528:DC%2BD3sXlsl2rsbs%3D 12888815 (Pubitemid 37026428)
10. A.A. Shleback P.I. Clark J.A. Green, et al. 1995 Hypersensitivity and cross-reactivity to cisplatin and analogues Cancer Chemother Pharmacol 35 349 351 10.1007/BF00689458
11. C. Koren R. Yerushalmi A. Katz, et al. 2002 Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy Am J Clin Oncol 25 625 626 10.1097/00000421-200212000-00020 12478013 (Pubitemid 35453673)
12. R. Basu A. Rajkumar N.R. Datta 2002 Anaphylaxis to cisplatin following nine previous uncomplicated cycles Int J Clin Oncol 7 365 367 10.1007/s101470200056 1:CAS:528:DC%2BD38Xps1Ohtbs%3D 12494253 (Pubitemid 36077320)
13. A. Polyzos N. Tsavaris C. Kosmas, et al. 2001 Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience Oncology 61 129 133 10.1159/000055363 1:CAS:528:DC%2BD3MXntFKjtL4%3D 11528251 (Pubitemid 32786206)
14. K.M. Zanotti L.A. Rybicki A.W. Kennedy, et al. 2001 Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy J Clin Oncol 19 3126 3129 1:CAS:528:DC%2BD3MXltFektLk%3D 11408510
15. M. Stahl W. Koster H. Wikle 2001 Reaction after oxaliplatin - prevention with corticosteroids? Ann Oncol 12 874 10.1023/A:1011161126611 1:STN:280:DC%2BD38%2FislSqtA%3D%3D 11484969 (Pubitemid 32655103)
16. J.S. Morgan M. Adams M.D. Mason 1994 Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma Eur J Cancer 30 1205 1206 10.1016/0959-8049(94)90489-8 (Pubitemid 24277855)
17. D. Santini G. Tonini A. Salerno, et al. 2001 Idiosyncratic reaction after oxaliplatin infusion Ann Oncol 12 132 133 10.1023/A:1008366223918 1:STN:280:DC%2BD3Mzit1Ojsw%3D%3D 11249043 (Pubitemid 32162461)
18. A.J. Newman Taylor P. Cullinan P.A. Lympany, et al. 1999 Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts Am J Respir Crit Care Med 160 435 438 1:STN:280:DyaK1MzlvFKkuw%3D%3D 10430710
19. M. Markmen A. Kennedy K. Webster, et al. 1999 Clinical features of hypersensitivity reactions to carboplatin J Clin Oncol 17 1141 1145
20. S. Sliesoraitis P.J. Chikhale 2005 Carboplatin hypersensitivity Int J Gynecol Cancer 15 13 18 10.1111/j.1048-891x.2005.14401.x 1:STN:280: DC%2BD2M%2FktlGhuw%3D%3D 15670291 (Pubitemid 40194327)
21. M.Y. Lee M.H. Yang J.H. Liu 2007 Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication Support Care Cancer 15 89 93 10.1007/s00520-006-0107-9 16865410 (Pubitemid 46088318)
22. L. Mis N.H. Fernando H.I. Hurwitz, et al. 2005 Successful desensitization to oxaliplatin Ann Pharmacother 39 966 969 10.1345/aph.1E532 15784807 (Pubitemid 40570680)
23. C. Tournigand A. Cervantes A. Figer, et al. 2006 OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer - a GERCOR study J Clin Oncol 24 394 400 10.1200/JCO.2005.03.0106 1:CAS:528:DC%2BD28XhsFSku7w%3D 16421419 (Pubitemid 46630458)